Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Jan;26(1):111–115. doi: 10.1128/jcm.26.1.111-115.1988

Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis.

J Blomberg 1, P J Klasse 1
PMCID: PMC266207  PMID: 3422645

Abstract

Electrophoretic immunoblotting (EIB [Western blotting]), the main method for verification of human immunodeficiency virus (HIV) seropositivity, needs thorough characterization and standardization. We explored the possibilities of quantifying immunoglobulin G (IgG) bound to EIB strips both by densitometry of the peroxidase-stained bands and by measurement of radioactivity with labeled anti-HIV IgG. The radioactivity method is inherently more exact but was more cumbersome. However, despite saturation phenomena at high IgG densities, the densitometric method was more convenient and yielded reproducible estimates of the amount of bound IgG. We found it useful primarily for documentation of changes in the relative abundance of antibodies to different HIV proteins from individual patients over time. To explore the potential usefulness of the method, we studied a small set of HIV-seropositive persons. The average p24/gp41 color yield ratios and standard deviations in 3 persons with recent seroconversion, 15 healthy subjects, and 6 diseased HIV-seropositive persons were 6.6 +/- 0.9, 2.3 +/- 1.9, and 1.3 +/- 0.5, respectively. These data are in accord with previous qualitative or semiquantitative observations but are too limited for any conclusions regarding the use of quantitative EIB for prognostic use with individual patients. Quantitative EIB is a valuable tool for comparative methodological studies and for research on the protective role of anti-HIV antibodies in acquired immunodeficiency syndrome pathogenesis. Its possible use in prognostication for individual patients must be evaluated in long-term studies.

Full text

PDF
111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barin F. AIDS vaccine predictions. Nature. 1987 Jul 2;328(6125):21–21. doi: 10.1038/328021a0. [DOI] [PubMed] [Google Scholar]
  2. Biberfeld G., Bredberg-Rådén U., Böttiger B., Putkonen P. O., Blomberg J., Juto P., Wadell G. Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet. 1986 Aug 2;2(8501):289–290. doi: 10.1016/s0140-6736(86)92111-2. [DOI] [PubMed] [Google Scholar]
  3. Biggar R. J., Melbye M., Ebbesen P., Alexander S., Nielsen J. O., Sarin P., Faber V. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) 1985 Oct 12;291(6501):997–998. doi: 10.1136/bmj.291.6501.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blake M. S., Johnston K. H., Russell-Jones G. J., Gotschlich E. C. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem. 1984 Jan;136(1):175–179. doi: 10.1016/0003-2697(84)90320-8. [DOI] [PubMed] [Google Scholar]
  5. Blomberg J., Klasse P. J., Kjelle'n L., Daniel M. D. Anti-STLV-IIImac reactivity in HIV seropositive individuals in Sweden. Lancet. 1986 Aug 9;2(8502):336–337. doi: 10.1016/s0140-6736(86)90019-x. [DOI] [PubMed] [Google Scholar]
  6. Blomberg J., Klasse P. J. Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting. J Clin Microbiol. 1988 Jan;26(1):106–110. doi: 10.1128/jcm.26.1.106-110.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burke D. S., Redfield R. R. False-positive Western blot tests for antibodies to HTLV-III. JAMA. 1986 Jul 18;256(3):347–347. [PubMed] [Google Scholar]
  8. Esteban J. I., Shih J. W., Tai C. C., Bodner A. J., Kay J. W., Alter H. J. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet. 1985 Nov 16;2(8464):1083–1086. doi: 10.1016/s0140-6736(85)90683-x. [DOI] [PubMed] [Google Scholar]
  9. Fang C. T., Darr F., Kleinman S., Wehling R. H., Dodd R. Y. Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting. Transfusion. 1986 Mar-Apr;26(2):208–209. doi: 10.1046/j.1537-2995.1986.26286152918.x. [DOI] [PubMed] [Google Scholar]
  10. Frösner G. G., Erfle V., Mellert W., Hehlmann R. Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins. Lancet. 1987 Jan 17;1(8525):159–160. doi: 10.1016/s0140-6736(87)91990-8. [DOI] [PubMed] [Google Scholar]
  11. Griswold D. E., Hillegass L., Antell L., Shatzman A., Hanna N. Quantitative Western blot assay for measurement of the murine acute phase reactant, serum amyloid P component. J Immunol Methods. 1986 Jul 24;91(2):163–168. doi: 10.1016/0022-1759(86)90474-6. [DOI] [PubMed] [Google Scholar]
  12. Groopman J. E., Chen F. W., Hope J. A., Andrews J. M., Swift R. L., Benton C. V., Sullivan J. L., Volberding P. A., Sites D. P., Landesman S. Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis. 1986 Apr;153(4):736–742. doi: 10.1093/infdis/153.4.736. [DOI] [PubMed] [Google Scholar]
  13. Lange J. M., Coutinho R. A., Krone W. J., Verdonck L. F., Danner S. A., van der Noordaa J., Goudsmit J. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Br Med J (Clin Res Ed) 1986 Jan 25;292(6515):228–230. doi: 10.1136/bmj.292.6515.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lange J., Goudsmit J. Decline of antibody reactivity to HIV core protein secondary to increased production of HIV antigen. Lancet. 1987 Feb 21;1(8530):448–448. doi: 10.1016/s0140-6736(87)90148-6. [DOI] [PubMed] [Google Scholar]
  15. Merrifield P. A., Konigsberg I. R. Reflective densitometry of Western blots to quantitate the developmentally regulated accumulation of myosin light chain 3. Biochem Biophys Res Commun. 1986 Mar 28;135(3):778–784. doi: 10.1016/0006-291x(86)90996-4. [DOI] [PubMed] [Google Scholar]
  16. Mortimer P. P., Parry J. V., Mortimer J. Y. Which anti-HTLV III/LAV assays for screening and confirmatory testing? Lancet. 1985 Oct 19;2(8460):873–877. doi: 10.1016/s0140-6736(85)90136-9. [DOI] [PubMed] [Google Scholar]
  17. Quinn T. C., Mann J. M., Curran J. W., Piot P. AIDS in Africa: an epidemiologic paradigm. Science. 1986 Nov 21;234(4779):955–963. doi: 10.1126/science.3022379. [DOI] [PubMed] [Google Scholar]
  18. Saxinger W. C., Levine P. H., Dean A. G., de Thé G., Lange-Wantzin G., Moghissi J., Laurent F., Hoh M., Sarngadharan M. G., Gallo R. C. Evidence for exposure to HTLV-III in Uganda before 1973. Science. 1985 Mar 1;227(4690):1036–1038. doi: 10.1126/science.2983417. [DOI] [PubMed] [Google Scholar]
  19. Schüpbach J., Haller O., Vogt M., Lüthy R., Joller H., Oelz O., Popovic M., Sarngadharan M. G., Gallo R. C. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med. 1985 Jan 31;312(5):265–270. doi: 10.1056/NEJM198501313120502. [DOI] [PubMed] [Google Scholar]
  20. Schüpbach J., Popovic M., Gilden R. V., Gonda M. A., Sarngadharan M. G., Gallo R. C. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science. 1984 May 4;224(4648):503–505. doi: 10.1126/science.6200937. [DOI] [PubMed] [Google Scholar]
  21. Thorell J. I., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta. 1971 Dec 28;251(3):363–369. doi: 10.1016/0005-2795(71)90123-1. [DOI] [PubMed] [Google Scholar]
  22. Tsang V. C., Hancock K., Maddison S. E. Quantitative capacities of glutaraldehyde and sodium m-periodate coupled peroxidase-anti-human IgG conjugates in enzyme-linked immunoassays. J Immunol Methods. 1984 May 11;70(1):91–100. doi: 10.1016/0022-1759(84)90393-4. [DOI] [PubMed] [Google Scholar]
  23. Ungar B. L., Nash T. E. Quantification of specific antibody response to Cryptosporidium antigens by laser densitometry. Infect Immun. 1986 Jul;53(1):124–128. doi: 10.1128/iai.53.1.124-128.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weber J. N., Clapham P. R., Weiss R. A., Parker D., Roberts C., Duncan J., Weller I., Carne C., Tedder R. S., Pinching A. J. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987 Jan 17;1(8525):119–122. doi: 10.1016/s0140-6736(87)91964-7. [DOI] [PubMed] [Google Scholar]
  25. Wendler I., Schneider J., Gras B., Fleming A. F., Hunsmann G., Schmitz H. Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) 1986 Sep 27;293(6550):782–785. doi: 10.1136/bmj.293.6550.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van der Poel C. L., Reesink H. W., Tersmette T., Lelie P. N., Huisman H., Miedema F. Blood donations reactive for HIV in Western blot, but non-infective in culture and recipients of blood. Lancet. 1986 Sep 27;2(8509):752–753. doi: 10.1016/s0140-6736(86)90273-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES